Valeant plans to redeem $150 million 6 3/8% senior notes on May 14

By Sarah Lizee

Olympia, Wash., April 12 – Valeant Pharmaceuticals International, Inc.’s wholly owned subsidiary, Valeant Pharmaceuticals International, will redeem its $150 million of 6 3/8% senior notes due 2020 using cash on hand on May 14, according to a press release.

The notes were originally issued in 2012.

Once the notes have been redeemed, Valeant's total long-term debt will be about $25.4 billion.

Valeant is a Laval, Quebec-based specialty pharmaceutical company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.